Stylianos Kakolyris

University Hospital of Alexandroupolis — Greece

Medicine · Health Sciences

37h-index5.1kcitations184works1.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Treatment and Pharmacology(53), Colorectal Cancer Treatments and Studies(44), Lung Cancer Treatments and Mutations(30), Cancer Genomics and Diagnostics(27), Epigenetics and DNA Methylation(17)

Publications182 total

Νovel methylation biomarkers in liquid biopsy and classifying biosignatures for the clinical management of Breast Cancer
2025Open Access
Abstract 1992: Detection rate for <i>ESR1</i> mutations is higher in CTC-derived genomic DNA than in paired plasma cfDNA samples as revealed by ddPCR
Cancer Research·2025
Detection rate for <scp> <i>ESR1</i> </scp> mutations is higher in circulating‐tumor‐cell‐derived genomic <scp>DNA</scp> than in paired plasma cell‐free <scp>DNA</scp> samples as revealed by <scp>ddPCR</scp>
Molecular Oncology·2025· 8 citedOpen Access
Direct comparison of an ultrasensitive real-time PCR assay with droplet digital PCR for the detection of PIK3CA hotspot mutations in primary tumors, plasma cell-free DNA and paired CTC-derived gDNAs
Frontiers in Oncology·2024· 2 citedOpen Access
Author response for "Detection rate for &lt;scp&gt;&lt;i&gt;ESR1&lt;/i&gt;&lt;/scp&gt; mutations is higher in circulating‐tumor‐cell‐derived genomic &lt;scp&gt;DNA&lt;/scp&gt; than in paired plasma cell‐free &lt;scp&gt;DNA&lt;/scp&gt; samples as revealed by &lt;scp&gt;ddPCR&lt;/scp&gt;"
2024
Detection of hotspot PIK3CA mutations in primary tumors and plasma-cfDNA of breast cancer patients using a novel highly sensitive CE-IVD KIT
Clinica Chimica Acta·2024
Abstract 2407: Detection of hotspot <i>PIK3CA</i> mutations in primary tumors and plasma-cfDNA of breast cancer patients using a novel highly sensitive CE-IVD kit
Cancer Research·2024
Abstract 7488: Detection of <i>PD-L1</i> mRNA expression in circulating tumor cells (CTCs) from patients with metastatic NSCLC, HNSCC and melanoma using a novel highly sensitive commercially available CE-IVD kit
Cancer Research·2024
Prognostic significance of BRCA1 and BRCA2 methylation status in circulating cell-free DNA of Pancreatic Cancer patients
Journal of Cancer·2024· 6 citedOpen Access
Implementing pharmacogenetic testing in fluoropyrimidine-treated cancer patients: DPYD genotyping to guide chemotherapy dosing in Greece
Frontiers in Pharmacology·2023· 11 citedOpen Access
Prognostic significance of <i>SOX17</i> and <i>WNT5a</i> promoter methylation status in circulating cell-free DNA metastatic colorectal cancer patients.
PubMed·2023· 7 citedOpen Access
Detection of ESR1 Mutations in Primary Tumors and Plasma Cell-Free DNA in High-Grade Serous Ovarian Carcinoma Patients
Cancers·2022· 10 citedOpen Access
Hypoxia and anaerobic metabolism relate with immunologically cold breast cancer and poor prognosis
Breast Cancer Research and Treatment·2022· 24 cited
<i>MTHFR</i> c.665C&gt;T guided fluoropyrimidine therapy in cancer: gender-dependent effect on dose requirements
Drug Metabolism and Personalized Therapy·2022· 7 citedOpen Access
Safety and Efficacy of RAD001 (Everolimus) Administered Upon Relapse During or After Adjuvant Treatment in Post-menopausal Women With Hormone Receptor Positive, HER2/neu Negative Locally Advanced or Metastatic Breast Cancer (CRAD001JGR08 “MELPOMENI” study)
Anticancer Research·2022· 5 cited
Prognostic Significance of SLFN11 Methylation in Plasma Cell-Free DNA in Advanced High-Grade Serous Ovarian Cancer
Cancers·2021· 21 citedOpen Access
Concentration of circulating tumour DNA in patients with metastatic gastric cancer and its prognostic significance
Forum of Clinical Oncology·2021· 1 citedOpen Access
Detection of Hepatocellular Carcinoma in a High-Risk Population by a Mass Spectrometry-Based Test
Cancers·2021· 8 citedOpen Access
Methylation Status of Corticotropin-Releasing Factor (CRF) Receptor Genes in Colorectal Cancer
Journal of Clinical Medicine·2021· 16 citedOpen Access
Gender-Dependent Association of <i>Tyms</i> -TSER Polymorphism With 5-Fluorouracil or Capecitabine-Based Chemotherapy Toxicity
Pharmacogenomics·2021· 10 cited
page 1 of 10Next →

Frequent Co-authors

Vassilis Georgoulias(11), Vassilis Georgoulias(10), John Souglakos(9), Εkaterini Chatzaki(9), Nikolaos Xenidis(8), Evi Lianidou(8), Ioanna Balgkouranidou(8), Paul Zarogoulidis(8), Ch. Kouroussis(7), George Samonis(7), Sofia Agelaki(7), D. Mavroudis(6), Ioannis Boukovinas(6), N. Androulakis(6), Nikolaos Ziras(5), Kostas Kalbakis(5), Leonidas Chelis(5), Kyriakos Amarantidis(5), Anastasios J. Karayiannakis(5), Dimitriοs Mavroudis(5)